rf-fullcolor.png

 

November 6, 2018
by Zachary Brennan

Real World Data App: FDA Releases Open Source Code

The US Food and Drug Administration (FDA) on Tuesday released computer code and a technical roadmap to allow researchers and app developers to use the agency’s newly created app that helps link real world data with electronic health data supporting clinical trials or registries.

FDA said the app and patient data storage system can be reconfigured by organizations conducting clinical research and can be rebranded by researchers and developers who would like to customize and rebrand it.

Among the features of the app is a secure data storage environment that supports auditing necessary for compliance with 21 CFR Part 11 and the Federal Information Security Management Act, so it can be used for trials under Investigational New Drug oversight.

The app is also configurable for different therapeutic areas and health outcomes, according to FDA, which reduces software development hurdles for non-FDA users. And the data storage environment is partitioned to support multi-site trials or “distributed database” studies, the agency added.

“The agency expects that the MyStudies app will aid researchers and industry in collecting real world patient level data and that these data, when linked to existing electronic health data, will promote efficiencies in drug development and drug safety monitoring processes,” FDA said.

Open source code is being released for two versions of the app: one on Apple’s ResearchKit (iOS) framework, and the other on the open source ResearchStack framework, which runs on Google’s Android.  

FDA’s MyStudies Application 
 
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.